You Are Here: Deltex Medical > Innovation Health & Wealth
Innovation Health & Wealth

Innovation Health & Wealth

Innovation Health and Wealth: Accelerating Adoption and Diffusion in the NHS, identified six High Impact Innovations to be widely diffused throughout the NHS, to improve productivity, quality and patient outcomes. Oesophageal Doppler Monitoring was one of six High Impact Innovations, recommended for widespread use in the NHS. The aim is to ‘launch a national drive to get full implementation of ODM, or similar fluid management monitoring technology, into practice across the NHS’.

Innovation Health and Wealth: Accelerating Adoption and Diffusion in the NHS, was published in December 2011. The report was designed to inform the strategic approach to innovation in the reformed NHS. It was prepared in consultation with industry, academia, clinicians and a wide range of other stakeholders, including those within the NHS. It was developed as part of the Prime Minister’s UK Strategy for Health Innovation and Life Sciences.

Innovation Health and Wealth identifies that innovation is central to the future of the NHS for three reasons:

  • Innovation transforms patient outcomes
  • Innovation can simultaneously improve quality and productivity
  • Innovation is good for economic growth

The focus of the report is to identify and mandate the adoption of High Impact Innovations in the NHS. Six High Impact Innovations were identified within the report:

  • 3 Million Lives
  • Oesophageal Doppler Monitoring (ODM)
  • Child in a Chair in a Day
  • International and Commercial Activity
  • Digital by Default
  • Carers for People with Dementia

The inclusion of ODM as a High Impact Innovation was largely due to the NICE Guidance, recommending the use of ODM for patients undergoing major or high-risk surgery:

“In March 2011, NICE published guidance on the use of ODM, recommending it for patients undergoing major or high-risk surgery and certain other surgical patients. Despite a comprehensive evidence base, uptake of this technology has been poor across the NHS. Full adoption of this technology across the NHS is forecast by NICE to benefit over 800,000 patients and generate net financial savings of over £400m. Current information suggests that these technologies are used for less than 10% of applicable patients.

We will launch a national drive to get full implementation of ODM, or similar fluid management monitoring technology, into practice across the NHS.”

The report also states that compliance with the six High Impact Innovations will be directly linked to CQUIN and they will become a pre-qualification requirement for CQUIN payments, as of 2013/14.

Innovation Health and Wealth: Accelerating Adoption and Diffusion in the NHS; IHW Report